Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 54

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 virus derivatives inhibitors cytostatic sars-cov cell nucleosides 1 review ATA HCV HIV-1 aureus cypa vivo
2 antiviral compounds binding HSV-1 SARS lines reaction 5 pyridine NA GL chromatography MIC cyclophilin in vivo
3 viral synthesized docking rna viruses 3clpro cancer reactions 3 hybrids ± rdrp gel antibiotics tylophorine JEV
4 activity activity enzyme DNA acute tumor nucleoside HBV n-oxide - anti-hcv transcriptase curcumin hsp90 emodin
5 replication series inhibitor VZV protease line sugar compound 1 scoring μg/ml SCV reverse staphylococcus cyclophilins arbidol
6 antiviral activity biological = viruses severe cell lines conditions isolated DFT myricetin polymerase trypsin ATCC cyclophilin a GRFT
7 infection synthesis cathepsin phosphonates syndrome cells nucleoside analogues 6 bases article rna-dependent channel antibacterial ppiase 3′-SL
8 viruses position molecular activity respiratory human formation 7 reactivity ZIKV gemcitabine blue FPR csa rhuifn-α
9 cells 2 inhibition = coronavirus benserazide analogues compound medicinal version replicons peptide MRSA EBOV nuclease
10 influenza relationship screening RNA 3CL proliferation surfactin % organic supplementary triphosphate ion bacteria silvestrol doses
11 effect complexes APN cytostatic activity PEDV mitochondrial yields 2 chemistry users helicase hiv-1 reverse transcriptase GR-SU cyps ®
12 reduction activities compounds simplex acute respiratory syndrome breast isatins 4 ring MATERIAL biosynthesis anti-hiv-1 SNH tylophorine compounds cephalotaxus
13 assay conjugates identified herpes 3cl(pro EGCG phosphoramidate anisodamine medicinal chemistry authorized 38 exchange GRA hpfabz homoharringtonine
14 50 SAR models acyclic inhibitory colon step compound 3 pyridine n-oxide derivatives SUPPLEMENTARY anti-hcv activity filtration mycobacterium peptidyl-prolyl kellalensis
15 effective group structure EC50 mpro MCF-7 nucleobases 1–4 hybrid ns2b-ns3(pro pyrimidine biosynthesis gel filtration staphylococcus aureus family PRV
16 in vitro antimicrobial small CEM cov < C-2 spectroscopic mannich online KAT2 ion exchange chromatography s. aureus cellular kuraridin
17 concentration showed modeling cytomegalovirus sars-cov 3clpro µm mol 9 schiff bases ELECTRONIC atpase CMV antibacterial activity EV71 experiments
18 inhibition moiety nm hela poms cancer cell lines deprotection 8) molecules online version MZP PT-1 peptide amifn-α mice
19 study order studies isoxazolidines CHIKV radical prodrugs sp. aromaticity dihydropyrimidinase MDH-1 superdex coli giant ×
20 vitro substituents diseases μm potent tea synthesis 14 electrostatic material GS-327073 antifungal escherichia RNP bioaron c®
21 drug 4 kinetic range sars-cov-2 lung efficient anti-inflammatory mannich bases patchouli alcohol IMPDH MT-4 PVA/PEI immunosuppressive cystatin
22 activities agents cysteine broad inhibitors NHC afford triterpenes PCA patchouli NS1040 sp-sepharose POM juglone promazine
23 antiviral activities analogues lead cultures anti-sars-cov anti-proliferative michael anti-hbv parameters neuraminidase resistant affi-gel blue gel antimicrobial cyclosporin piscidin
24 assays active μm L1210 Q7R scavenging prodrug hbsag systems dihydromyricetin pyrimidine affinity chromatography gram C003 alfacon1
25 concentrations potential DNMT1 endowed anti-sars CBS protected tomentin applications ru hepatitis c virus antifungal peptide susceptibility isomerase pentoxifylline
26 entry structure IC(50 human cytomegalovirus hydrolase acid converted hbeag chemical AMP tenofovir SPL minimum B(2 interferon alfacon1
27 cytotoxicity studies proteases HEL P3 hepg2 adenine extraction functions yoph adks seeds trifluoroketone subtypes H9N2
28 plaque promising virtual antiviral activity warhead cell line cytosine urine heterocycles 0.2 de affi-gel DQP-1105 BTV pps
29 action modification design HSV-2 SAH tumour azido compound 1a NBO mm novo l1210 cells gram-positive hpcgs dose
30 inhibited NMR site HCMV inhibitory activity HT-29 final 1a H⋯O mutans AT-511 growth quinocetone c-myc bioaron
31 inhibit groups potent plasmodium 3cl protease 18α desired nitric charge cqds atpase activity inhibited qdnos hpfabd ml−1
32 extracts bearing cathepsin l falciparum syndrome-coronavirus K562 SLP5 pl(pro density etoac DENV2 RT M. HEV cystatin d
33 ribavirin comparable screen EC(50 lopinavir prostate readily lamivudine five-membered kaempferol EBV XILP sulfhydryl panda anti-mtb
34 results reference plpro plasmodium falciparum CEP C30 hepg2 cells alcohols ADV terms GCG inhibitors B#24 vancomycin decades aloe
35 human modifications hexachlorophene acyclic nucleoside phosphonates ACE2 β-cd steps sulfur chemists HMA GSK983 10i amino acid hsp90 inhibitors japanese encephalitis virus
36 dengue prepared hit isoxazolidine acute respiratory syndrome coronavirus hep-g2 analogue side-chain section kcal glycyrrhizic A/M2 amino acids ppiases 10(−5
37 compounds IR papain alkynes mers-cov HCT116 deacetylation ferruginol title IC(50 NS5B 75 VSV non-immunosuppressive artesunate
38 found evaluated I50 tricyclic darunavir angiogenesis facile quinone-methide energy active site glycyrrhizic acid ph amino cis-trans mg/kg
39 infections exhibited k(i punta E6 china intermediates HRESIMS schiff EV71 MOP anti-hiv strains C003/C052 assay
40 disease metal 3D varicella-zoster IC50 ± 6-chloropurine hepg biological activity sapria LCTA-949 L1210 PD3 C052 interferon
41 % antiviral andrographolide toro sars-cov mpro IC(50 oxindoles n-dimethylamino-2′,3′-dideoxythymidine presented μg/ml. N30 dlasil W190/N192 A(2A glycosylated
42 SI general domain exhibited 1-position pis base roots chalcogen 3i hsc70 peg5kc34 bactericidal smcypi HHT
43 viral replication biological activities comfa evaluated PRRSV NQ groups P11A carbamates (-)-α-pinene enzymes PRL RW3 saikosaponins UL12
44 cell synthesized compounds active anps 3c-like H2S key antigen 2004 baicalein involved pegylated R190/K192 role simultaneous
45 showed found results sindbis antiviral potential PGG unprotected hydroxyanisodamine external (-)-β-pinene hepatitis dsclerl PD4 protein mouse model
46 cytopathic compound molecular modeling TK(+ octahydroisochromene 7e methodology structures orbital 95 HIV lymphoma ossgt1 complex mtb
47 infectious newly molecular docking 4b 3cpro tannic 6-chloropurine-2′-deoxyriboside 12 cross-validation mm. aglycone peg2kc34 mycoplasma host MES
48 efficacy elemental study series ritonavir hldh-a alder 8 fluorinated chloroform prep atanyl changing proteins alkaloids
49 FIPV benzotriazole comsia antiviral P1 compound friedel 10 centroid site public mt-4 cells R190/N192 play FGIN-1
50 CPE years generated human substituent in vitro deprotected determined shuffling influenza combination C34 steroids virostatic violet